Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. OTC Markets
  5. Pharma-Bio Serv, Inc.
  6. Summary
    PBSV   US71711N1000

PHARMA-BIO SERV, INC.

(PBSV)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Otc Markets
09/14/2021 09/15/2021 09/16/2021 09/17/2021 09/20/2021 Date
1.08(c) 1.14(c) 1.11(c) 1(c) 1.01 Last
200 1 005 1 865 28 900 25 569 Volume
+0.93% +5.56% -2.63% -9.91% +1.00% Change
More quotes
Estimated financial data (e) (USD)
Sales 2021 20,3 M - -
Net income 2021 - - -
Net Debt 2021 - - -
P/E ratio 2021 -
Yield 2021 -
Sales 2022 22,9 M - -
Net income 2022 - - -
Net Debt 2022 - - -
P/E ratio 2022 -
Yield 2022 -
Capitalization 23,0 M 23,0 M -
Capi. / Sales 2021 1,13x
Capi. / Sales 2022 1,01x
Nbr of Employees 220
Free-Float 35,2%
More Financials
Company
Pharma-Bio Serv, Inc. is a compliance and technology transfer services consulting company. The Company operates through four segments: Puerto Rico technical compliance consulting, United States technical compliance consulting, Europe technical compliance consulting, and Puerto Rico microbiological and chemical laboratory testing division (Lab). The Company provides a range of compliance-related consulting services.... 
More about the company
All news about PHARMA-BIO SERV, INC.
09/14PHARMA-BIO SERV, INC. : Results of Operations and Financial Condition, Financial..
AQ
09/14PHARMA BIO SERV : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AN..
AQ
09/14Pharma-Bio Serv, Inc. Reports Earnings Results for the Third Quarter Ended Ju..
CI
06/14PHARMA-BIO SERV, INC. : Results of Operations and Financial Condition (form 8-K)
AQ
06/14PHARMA BIO SERV : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AN..
AQ
06/14Tranche Update on Pharma-Bio Serv, Inc.'s Equity Buyback Plan announced on Ju..
CI
06/14Pharma-Bio Serv, Inc. Reports Earnings Results for the Second Quarter Ended A..
CI
06/03PHARMA-BIO SERV, INC. : Submission of Matters to a Vote of Security Holders (for..
AQ
05/06PHARMA-BIO SERV, INC. : Other Events (form 8-K)
AQ
03/22INSIDER TRENDS : 90-Day Insider Selling Trend Prolonged at Pharma-Bio Serv
MT
03/17PHARMA-BIO SERV, INC. : Results of Operations and Financial Condition, Financial..
AQ
03/17PHARMA BIO SERV : Management's discussion and analysis of financial condition an..
AQ
03/17Tranche Update on Pharma-Bio Serv, Inc.'s Equity Buyback Plan announced on Ju..
CI
02/01PHARMA-BIO SERV, INC. : Results of Operations and Financial Condition, Financial..
AQ
02/01PHARMA BIO SERV : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AN..
AQ
More news
News in other languages on PHARMA-BIO SERV, INC.

- No features available -

More news
Chart PHARMA-BIO SERV, INC.
Duration : Period :
Pharma-Bio Serv, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 0
Last Close Price 1,01 $
Average target price 2,11 $
Spread / Average Target 109%
Managers and Directors
Victor Sanchez President & Chief Executive Officer
Pedro J. Lasanta CFO, Secretary & Vice President-Administration
Kirk Wheeler Michel Chairman
Dov Perlysky Independent Non-Executive Director
Howard Spindel Independent Director
Sector and Competitors